
Robert Jenkins
Examiner (ID: 15672)
| Most Active Art Unit | 2402 |
| Art Unit(s) | 1726, 3405, 2899, 1302, 2402 |
| Total Applications | 1932 |
| Issued Applications | 1833 |
| Pending Applications | 19 |
| Abandoned Applications | 80 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11304790
[patent_doc_number] => 09512175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Macrocyclic inhibitors of flaviviridae viruses'
[patent_app_type] => utility
[patent_app_number] => 14/821458
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 175573
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14821458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/821458 | Macrocyclic inhibitors of flaviviridae viruses | Aug 6, 2015 | Issued |
Array
(
[id] => 11798534
[patent_doc_number] => 09539253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Pyrimidine diol amides as sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 14/817984
[patent_app_country] => US
[patent_app_date] => 2015-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29672
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14817984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/817984 | Pyrimidine diol amides as sodium channel blockers | Aug 3, 2015 | Issued |
Array
(
[id] => 10422532
[patent_doc_number] => 20150307544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'DITHIOAMINE REDUCING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/793519
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24254
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793519
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793519 | DITHIOAMINE REDUCING AGENTS | Jul 6, 2015 | Abandoned |
Array
(
[id] => 12790672
[patent_doc_number] => 20180155393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => HEPATITIS C VIRUS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/317555
[patent_app_country] => US
[patent_app_date] => 2015-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317555 | Hepatitis C virus inhibitors | Jun 22, 2015 | Issued |
Array
(
[id] => 12962602
[patent_doc_number] => 09873716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Macrocyclic inhibitors of flaviviridae viruses
[patent_app_type] => utility
[patent_app_number] => 14/740680
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65767
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14740680
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/740680 | Macrocyclic inhibitors of flaviviridae viruses | Jun 15, 2015 | Issued |
Array
(
[id] => 10756179
[patent_doc_number] => 20160102332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'METHODS FOR MAKING TARGETED PROTEIN TOXINS BY SORTASE-MEDIATED PROTEIN LIGATION'
[patent_app_type] => utility
[patent_app_number] => 14/727017
[patent_app_country] => US
[patent_app_date] => 2015-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12564
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727017
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/727017 | METHODS FOR MAKING TARGETED PROTEIN TOXINS BY SORTASE-MEDIATED PROTEIN LIGATION | May 31, 2015 | Abandoned |
Array
(
[id] => 11625897
[patent_doc_number] => 20170136085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'TARGETED THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 15/314769
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29482
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314769 | TARGETED THERAPEUTICS | May 28, 2015 | Abandoned |
Array
(
[id] => 11662008
[patent_doc_number] => 20170150714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'ANTIMICROBIAL PREPARATIONS, METHODS FOR PREPARING THE SAME AND USES THEREOF TO COMBAT MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 15/314248
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26010
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314248 | Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms | May 27, 2015 | Issued |
Array
(
[id] => 15381847
[patent_doc_number] => 10532082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => SOCS1-derived peptide for use in chronic complications of diabetes
[patent_app_type] => utility
[patent_app_number] => 15/314395
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 9241
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314395
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314395 | SOCS1-derived peptide for use in chronic complications of diabetes | May 26, 2015 | Issued |
Array
(
[id] => 10685756
[patent_doc_number] => 20160031902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'NOVEL MAYTANSINOID DERIVATIVES WITH SULFOXIDE LINKER'
[patent_app_type] => utility
[patent_app_number] => 14/718350
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19342
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718350
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/718350 | Maytansinoid derivatives with sulfoxide linker | May 20, 2015 | Issued |
Array
(
[id] => 11595745
[patent_doc_number] => 09642889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Macrocyclic inhibitors of Flaviviridae viruses'
[patent_app_type] => utility
[patent_app_number] => 14/719242
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 130964
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/719242 | Macrocyclic inhibitors of Flaviviridae viruses | May 20, 2015 | Issued |
Array
(
[id] => 16229402
[patent_doc_number] => 10736932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Small molecule Ras inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/312593
[patent_app_country] => US
[patent_app_date] => 2015-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 19798
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312593
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312593 | Small molecule Ras inhibitors | May 18, 2015 | Issued |
Array
(
[id] => 10444579
[patent_doc_number] => 20150329593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'Synthesis of Beta-Arrestin Effectors'
[patent_app_type] => utility
[patent_app_number] => 14/715595
[patent_app_country] => US
[patent_app_date] => 2015-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15094
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715595 | Synthesis of beta-arrestin effectors | May 18, 2015 | Issued |
Array
(
[id] => 10353582
[patent_doc_number] => 20150238587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'WT1 ANTIGEN PEPTIDE CONJUGATE VACCINE'
[patent_app_type] => utility
[patent_app_number] => 14/706772
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 46548
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706772
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/706772 | WT1 antigen peptide conjugate vaccine | May 6, 2015 | Issued |
Array
(
[id] => 10459508
[patent_doc_number] => 20150344523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'MUTANT AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING'
[patent_app_type] => utility
[patent_app_number] => 14/704865
[patent_app_country] => US
[patent_app_date] => 2015-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 34169
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/704865 | MUTANT AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING | May 4, 2015 | Abandoned |
Array
(
[id] => 10412660
[patent_doc_number] => 20150297669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING MEDICAL CONDITIONS AND A METHOD FOR TREATING ALIMENTARY DISORDERS AND RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/703466
[patent_app_country] => US
[patent_app_date] => 2015-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4692
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14703466
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/703466 | Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases | May 3, 2015 | Issued |
Array
(
[id] => 11553620
[patent_doc_number] => 20170099866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'CONCENTRATED LIQUID FOOD'
[patent_app_type] => utility
[patent_app_number] => 15/304281
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25385
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304281 | Concentrated liquid food | Apr 16, 2015 | Issued |
Array
(
[id] => 10333220
[patent_doc_number] => 20150218224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Solution Phase Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates'
[patent_app_type] => utility
[patent_app_number] => 14/686899
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15104
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14686899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/686899 | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates | Apr 14, 2015 | Issued |
Array
(
[id] => 11434872
[patent_doc_number] => 20170035894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'DRUG DELIVERY CONJUGATES FOR TREATING RESISTANT CANCER AND FOR USE IN COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/303953
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18018
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303953
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303953 | DRUG DELIVERY CONJUGATES FOR TREATING RESISTANT CANCER AND FOR USE IN COMBINATION THERAPY | Apr 13, 2015 | Abandoned |
Array
(
[id] => 11401715
[patent_doc_number] => 20170022254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'Novel Aldehyde Acetal Based Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates'
[patent_app_type] => utility
[patent_app_number] => 15/301831
[patent_app_country] => US
[patent_app_date] => 2015-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29765
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301831 | Novel Aldehyde Acetal Based Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates | Apr 6, 2015 | Abandoned |